Comparison of a solid phase human- versus porcine-thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue SUPPL. 1, 2008, Pages

  Hermsen, D ^a   Liu, C ^a,b   Domberg, J ^a   Graeber, C ^a   Feldkamp, J ^c   Duan, Y ^b   Xu, K ^b   Mao, X ^b   Scherbaum, W A ^a   Schott, Matthias ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Municipal Hospital Bielefeld   (Germany)

Author keywords

ELISA; Graves disease; Second generation TRAb assay; Thyrotropin receptor antibody

Indexed keywords

THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOCRINE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHYROID NODULAR THYROID DISEASE; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID PHASE PORCINE THYROTROPIN RECEPTOR BASED IMMUNOASSAY; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

ANIMALS; ANTIBODY SPECIFICITY; CHEMILUMINESCENT MEASUREMENTS; CROSS REACTIONS; GOITER, NODULAR; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULINS, THYROID-STIMULATING; IODIDE PEROXIDASE; RECEPTORS, THYROID HORMONE; RECEPTORS, THYROTROPIN; SWINE; THYROID DISEASES;

EID: 54549114361     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081491     Document Type: Article

References (28)

1. Weetman AP. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 2004; 61: 405-413
2. Guarneri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Cur Opin Endocrinol Diab Obes 2007; 14: 398-409
3. Rapoport B, MacLachlan SM. The thyrotropin receptor in Graves' disease. Thyroid 2007; 17: 911-922
4. Rees Smith B, Sanders J, Furmaniak J. TSH receptor antibodies. Thyroid 2007; 17: 928-938
5. Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab 2005; 16: 243-248
6. Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves'disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf) 2001; 55 (3): 381-390
7. Paunkovic N, Paunkovic J. The diagnostic criteria of Graves' disease and especially the thyrotropin receptor antibody: our own experience. Hell J Nucl Med 2007; 10: 89-94
8. Izumi Y, Takeoka K, Amino N. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiated relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease. Endocr J 2005; 52: 493-497
9. Eckstein AK, Plicht M, Lax H, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006; 91: 3464-3470
10. Abraham P, Avenell A, Park CM, Watson WA, Bevan JS. A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol 2005; 153: 489-498
11. Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. Horm Metab Res 2000; 32 (10): 429-435
12. Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatmem and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid 2006; 16: 295-302
13. Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, Seiissler J. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 2004; 36: 92-96
14. Hoermann R, Quadbeck B, Roggenbuck U, Szabolcs I, Pfeilschifter J, Meng W, Reschke K, Hackenberg K, Dettmann J, Prehn B, Hirche H, Mann K. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: Results of a prospective randomized study on the use of levothyroxine. Thyroid 2002: 12: 1119-1128
15. Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, Pirola I, Martino ED, Rosei EA. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study. Endocr J 2007; 54 (5): 713-720
16. Schott M, Eckstein A, Willenberg HS, Nguyen T-B-T, Morgenthaler NG, Scherbaum WA. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. Horm Metab Res 2007; 39: 56-61
17. Morgenthaler NG. New assay systems for thyroid receptor antibodies. Current Opin Endocrinol Diabetes 1999: 6: 251-260
18. Zoephel K, Wunderlich G. Predictive value of TSH receprot antibody measurement in Graves' disease is independent on the TSH receptor (human or porcine) but depends on the generation of the assay used. Endocr J 2006; 53: 869-870
19. Okamoto Y, Tanigawa SI, Ishikawa K, Hamada N. Ths receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs. Endocr J 2006; 53: 467-472
20. Cardia MS, Lima N, Knobel M, Medeiros-Neto G. Evaluvgtion of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders. Thyroid 2004; 14: 295-300
21. Feldt-Rasmussen U, Schleusner H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long-term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 1994; 78: 98-102
22. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglohner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger P-M, Bergmann A, Mann K, Vassart G, Usadel K-H. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999; 84: 90-97
23. Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr J 2003; 50 (1): 113-116
24. Rees Smith B, Bolton J, Young S, Collyer A, Weeden A, Bradburg J, Weightman D, Perros P, Sanders J, Furmaniak J. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004; 14: 830-835
25. Abalovich M, Amino N, Barbour LA, Cobin RH, Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green AI. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2007; 92: S1-S47
26. Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M, Toubert ME, Léger J, Boissinot C, Schlageter MH, Garel C, Tébeka B, Oury JF, Czernichow P, Polak M. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005; 90 (11): 6093-6098
27. Chan GW, Mandel SJ. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Enclocrinol Metab 2007; 3 (6): 470-478
28. Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. Thyroid 2005; 15 (9): 1047-1054